Bionano Genomics (BNGO) Expected to Announce Quarterly Earnings on Thursday

Posted by Editorial Team on Aug 12th, 2025

Bionano Genomics (NASDAQ:BNGO – Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 14th. Analysts expect Bionano Genomics to post earnings of ($2.69) per share and revenue of $6.90 million for the quarter. Bionano Genomics has set its Q2 2025 guidance at EPS.

Bionano Genomics (NASDAQ:BNGO – Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported ($1.15) earnings per share for the quarter, beating the consensus estimate of ($3.49) by $2.34. The company had revenue of $6.46 million during the quarter, compared to analyst estimates of $6.25 million. Bionano Genomics had a negative net margin of 294.05% and a negative return on equity of 125.75%.

Bionano Genomics Price Performance

BNGO opened at $2.93 on Tuesday. The firm has a market cap of $9.84 million, a P/E ratio of -0.02 and a beta of 2.06. The firm has a 50-day moving average of $3.35 and a 200 day moving average of $3.85. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.34 and a current ratio of 1.70. Bionano Genomics has a fifty-two week low of $2.68 and a fifty-two week high of $37.09.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Bionano Genomics from a “sell” rating to a “hold” rating in a research report on Saturday. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $7.00.

Check Out Our Latest Stock Report on Bionano Genomics

Bionano Genomics Company Profile

(Get Free Report)

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.